DEVICE: BIGmack (00850011150061)
Device Identifier (DI) Information
BIGmack
10000041
In Commercial Distribution
10000041
Ablenet, Inc.
10000041
In Commercial Distribution
10000041
Ablenet, Inc.
Start your communication journey with a BIGmack speech device. With a press of the large colored top, an individual can communicate a single message up to 2-minutes long. New messages are easily and quickly recorded to the BIGmack on the fly throughout the day to provide opportunities to communicate in almost any scenario.
Includes ableCARE on-demand support
Built ableSTRONG to endure drops and other environmental conditions
Made from ableSAFE materials and tested by third-party safety labs
Common Uses
Request like "I want" or "I need help"
Participate in an activity with "turn the page" or "It's your turn"
Tell your classmates what you did over the weekend during a morning meeting
Add communication to a switch controlled toy or applianceg
Features
Better than ever digital sound output suitable for almost any environment
Includes red, yellow, green, and blue colored tops
Clear snap cover to attach picture symbols and provide communication context to the user
Soft-touch coating makes the device easier to hold
Symbol Overlays
Symbol overlays are not included with the BIGmack. Download the free AbleNet Symbol Overlay app for iPad to create symbol overlays for your AbleNet speech device.
Device Characteristics
Labeling does not contain MRI Safety Information | |
No | |
No | |
No | |
No | |
No | |
No | |
No | |
No |
GMDN
[?]GMDN© Term Code, Names and Definitions (*Terms of Use): GMDN® is a registered trademark of The GMDN Agency. All rights reserved. Used under licence from The GMDN Agency Ltd.
GMDN Term Code | GMDN Term Name | GMDN Term Definition | GMDN Term Status [?] | Implantable? |
---|---|---|---|---|
65757 | Uncarboxylated matrix Gla protein (ucMGP) IVD, kit, chemiluminescent immunoassay |
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of uncarboxylated matrix Gla-protein (ucMGP) in a clinical specimen, using a chemiluminescent immunoassay method. This test is typically used to assess arterial walls for status of vitamin K, which if deficient leads to high levels of the inactive ucMGP accumulating at sites of arterial calcification causing arterial stiffness.
|
Active | false |
FDA Product Code
[?]Product Code | Product Code Name |
---|---|
ILQ | System, Communication, Powered |
FDA Premarket Submission
FDA Premarket Submission Number [?] | Supplement Number [?] |
---|---|
Premarket Submission Number Not Available/Not Released |
Sterilization
Storage and Handling
[?]Storage and Handling |
---|
No storage/handling found |
Clinically Relevant Size
[?]Size Type Text |
---|
No Device Sizes |
Device Record Status
6a6dad6e-4a02-4930-9a33-dbebb04d3311
June 29, 2023
1
June 21, 2023
June 29, 2023
1
June 21, 2023
Alternative and Additional Identifiers Additional Identifiers
Package DI
[?]Package DI Number | Quantity per Package | Contains DI Package | Package Discontinue Date | Package Status | Package Type |
---|---|---|---|---|---|
No Package DIs found |
Secondary DI
[?]Issuing Agency [?] | Secondary DI Number |
---|---|
No Secondary DIs found |
Unit of Use DI
[?]
Unit of Use DI Number:
No Unit of Use DI Numbers Found
CLOSE
Direct Marking (DM)
[?]Production Identifier(s) in UDI
[?]Customer Contact
[?]
No Customer Contact currently defined